| Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: comparison of fluvoxamine and desipramine WK Goodman, LH Price, PL Delgado, J Palumbo, JH Krystal, LM Nagy, ... Archives of General Psychiatry 47 (6), 577-585, 1990 | 431 | 1990 |
| A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia GJ Pandina, JP Lindenmayer, J Lull, P Lim, S Gopal, V Herben, ... Journal of clinical psychopharmacology 30 (3), 235-244, 2010 | 273 | 2010 |
| Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. SL Satel, LH Price, JM Palumbo, CJ McDougle, JH Krystal, F Gawin, ... The American journal of psychiatry 148 (12), 1712-1716, 1991 | 225 | 1991 |
| Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder JA Quiroz, LN Yatham, JM Palumbo, K Karcher, S Kushner, V Kusumakar Biological psychiatry 68 (2), 156-162, 2010 | 186 | 2010 |
| Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose … LA Adler, B Zimmerman, HL Starr, S Silber, J Palumbo, C Orman, ... Journal of clinical psychopharmacology 29 (3), 239-247, 2009 | 144 | 2009 |
| A randomized, placebo‐and active‐controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder E Vieta, IF Nuamah, P Lim, EC Yuen, JM Palumbo, DW Hough, ... Bipolar disorders 12 (3), 230-243, 2010 | 121 | 2010 |
| Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies R Emsley, J Berwaerts, M Eerdekens, M Kramer, R Lane, P Lim, D Hough, ... International Clinical Psychopharmacology 23 (6), 343-356, 2008 | 116 | 2008 |
| Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia S Gopal, C Gassmann-Mayer, J Palumbo, MN Samtani, R Shiwach, ... Current medical research and opinion 26 (2), 377-387, 2010 | 98 | 2010 |
| Edaravone and its clinical development for amyotrophic lateral sclerosis K Takei, K Watanabe, S Yuki, M Akimoto, T Sakata, J Palumbo Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18 (sup1), 5-10, 2017 | 92 | 2017 |
| A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia R Luthringer, L Staner, N Noel, M Muzet, C Gassmann-Mayer, K Talluri, ... International clinical psychopharmacology 22 (5), 299-308, 2007 | 90 | 2007 |
| Dosing and switching strategies for paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial data MN Samtani, S Gopal, C Gassmann-Mayer, L Alphs, JM Palumbo CNS drugs 25, 829-845, 2011 | 88 | 2011 |
| Regional cerebral blood flow during acute and chronic abstinence from combined cocaine–alcohol abuse TR Kosten, C Cheeves, J Palumbo, JP Seibyl, LH Price, SW Woods Drug and alcohol dependence 50 (3), 187-195, 1998 | 75 | 1998 |
| Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study LA Adler, C Orman, HL Starr, S Silber, J Palumbo, K Cooper, J Berwaerts, ... Journal of clinical psychopharmacology 31 (1), 108-114, 2011 | 71 | 2011 |
| Methods for treatment of sexual dysfunction J Palumbo, J Sporn, T Steckler, Y Choi, JS Lee US Patent 8,552,060, 2013 | 56 | 2013 |
| Treatment of sleep-wake disorders A Ahnaou, WHLM Drinkenburg, J Palumbo, J Sporn US Patent 8,440,715, 2013 | 54 | 2013 |
| An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United … K Takei, K Tsuda, F Takahashi, M Hirai, J Palumbo Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18 (sup1), 88-97, 2017 | 40 | 2017 |
| Treatment of sleep-wake disorders A Ahnaou, WHIM Drinkenburg, J Palumbo, J Sporn US Patent 8,877,806, 2014 | 40 | 2014 |
| A 24-week, phase III, double-blind, parallel-group study of edaravone (MCI-186) for treatment of amyotrophic lateral sclerosis (ALS)(P3. 189) M Tanaka, T Sakata, J Palumbo, M Akimoto Neurology 86 (16_supplement), P3. 189, 2016 | 36 | 2016 |
| Risk of cardiovascular morbidity with risperidone or paliperidone treatment: analysis of 64 randomized, double-blind trials S Gopal, D Hough, K Karcher, I Nuamah, J Palumbo, JA Berlin, ... Journal of clinical psychopharmacology 33 (2), 157-161, 2013 | 36 | 2013 |
| Post-hoc analysis of MCI186-17, the extension study to MCI186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral … F Takahashi, K Takei, K Tsuda, J Palumbo Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18 (sup1), 32-39, 2017 | 34 | 2017 |
